Takeda Pharmaceutical annual gross margin
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Takeda Pharmaceutical Gross Margin Growth & History (TAK)
Takeda Pharmaceutical's gross margin was 65.12% for fiscal 2026.
View full Takeda Pharmaceutical company overviewTakeda Pharmaceutical annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2026 | 2026-03-31 | 65.12% | −0.39 pp |
| 2025 | 2025-03-31 | 65.51% | −1.03 pp |
| 2024 | 2024-03-31 | 66.54% | −2.57 pp |
| 2023 | 2023-03-31 | 69.11% | +0.12 pp |
| 2022 | 2022-03-31 | 68.99% | +0.08 pp |
| 2021 | 2021-03-31 | 68.91% | +2.02 pp |
| 2020 | 2020-03-31 | 66.89% | −2.04 pp |
| 2019 | 2019-03-31 | 68.92% | −3.07 pp |
| 2018 | 2018-03-31 | 71.99% | +4.25 pp |
| 2017 | 2017-03-31 | 67.74% | — |
Takeda Pharmaceutical gross margin trends
Over the last five fiscal years, Takeda Pharmaceutical's gross margin decreased from 68.91% to 65.12%, a change of −3.79 percentage points.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Takeda Pharmaceutical source filings ↗